• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动静脉畸形栓塞的直接血液动力学效应。

Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation.

机构信息

Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, the Netherlands,

出版信息

Neth Heart J. 2014 Aug;22(7-8):328-33. doi: 10.1007/s12471-014-0539-7.

DOI:10.1007/s12471-014-0539-7
PMID:24604121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4099429/
Abstract

BACKGROUND

Transcatheter embolisation is widely used to close pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). Data on the direct cardiovascular haemodynamic changes induced by this treatment are scarce.

OBJECTIVES

We investigated the direct haemodynamic effects of transcatheter embolisation of PAVMs, using non-invasive finger pressure measurements.

METHODS

During the procedure, blood pressure, heart rate (HR), stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and delta pressure/delta time (dP/dt) were continuously monitored using a Finometer®. Potential changes in these haemodynamic parameters were calculated from the pressure registrations using Modelflow® methodology. Absolute and relative changes were calculated and compared using the paired sample t-test.

RESULTS

The present study includes 29 HHT patients (mean age 39 ± 15 years, 11 men) who underwent transcatheter embolotherapy of PAVMs. The total number of embolisations was 72 (mean per patient 2.5). Directly after PAVM closure, SV and CO decreased significantly by -11.9 % (p = 0.01) and -9.5 % (p = 0.01) respectively, without a significant change in HR (1.8 %). Mean arterial blood pressure increased by 4.1 % (p = 0.02), while the TPR and dP/dt did not increase significantly (5.8 % and 0.2 %, respectively).

CONCLUSIONS

Significant haemodynamic changes occur directly after transcatheter embolisation of PAVMs, amongst which a decrease in stroke volume and cardiac output are most important.

摘要

背景

经导管栓塞术被广泛用于治疗遗传性出血性毛细血管扩张症(HHT)患者的肺动静脉畸形(PAVM)。关于这种治疗方法直接引起的心血管血液动力学变化的数据很少。

目的

我们使用非侵入性手指压力测量来研究经导管 PAVM 栓塞治疗引起的直接血液动力学效应。

方法

在手术过程中,使用 Finometer®连续监测血压、心率(HR)、每搏量(SV)、心输出量(CO)、总外周阻力(TPR)和压力/时间变化率(dP/dt)。使用 Modelflow®方法从压力记录中计算这些血液动力学参数的潜在变化。使用配对样本 t 检验计算绝对和相对变化,并进行比较。

结果

本研究包括 29 例 HHT 患者(平均年龄 39±15 岁,男性 11 例),这些患者接受了 PAVM 的经导管栓塞治疗。总共进行了 72 次栓塞(平均每位患者 2.5 次)。PAVM 关闭后,SV 和 CO 直接分别显著下降 11.9%(p=0.01)和 9.5%(p=0.01),而 HR 无明显变化(1.8%)。平均动脉血压升高 4.1%(p=0.02),而 TPR 和 dP/dt 没有明显增加(分别为 5.8%和 0.2%)。

结论

经导管 PAVM 栓塞后会立即发生显著的血液动力学变化,其中 SV 和 CO 的下降最为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3656/4099429/e060570aacce/12471_2014_539_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3656/4099429/e060570aacce/12471_2014_539_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3656/4099429/e060570aacce/12471_2014_539_Fig1_HTML.jpg

相似文献

1
Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation.肺动静脉畸形栓塞的直接血液动力学效应。
Neth Heart J. 2014 Aug;22(7-8):328-33. doi: 10.1007/s12471-014-0539-7.
2
Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.缺血性中风/脑脓肿风险的主要决定因素与遗传性出血性毛细血管扩张症中肺动静脉畸形的严重程度无关。
Thorax. 2008 Mar;63(3):259-66. doi: 10.1136/thx.2007.087452. Epub 2007 Nov 2.
3
Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasia.遗传性出血性毛细血管扩张症患者肺和脑动静脉畸形的血管内治疗
Curr Pharm Des. 2006;12(10):1243-8. doi: 10.2174/138161206776361237.
4
Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中小的未经治疗的肺动静脉畸形的随访间隔
Clin Radiol. 2017 Mar;72(3):236-241. doi: 10.1016/j.crad.2016.12.002. Epub 2016 Dec 29.
5
Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy.肺动静脉畸形:诊断与经导管栓塞治疗
J Vasc Interv Radiol. 1996 Nov-Dec;7(6):787-804. doi: 10.1016/s1051-0443(96)70851-5.
6
Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia.无声的威胁?遗传性出血性毛细血管扩张症患者肺动静脉畸形筛查实践的回顾性研究。
Rhinology. 2012 Sep;50(3):277-83. doi: 10.4193/Rhino12.043.
7
Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia.伴有肺动静脉畸形和遗传性出血性毛细血管扩张症的危及生命的肺出血
Chest. 1994 Nov;106(5):1387-90. doi: 10.1378/chest.106.5.1387.
8
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study.非遗传性出血性毛细血管扩张症患者的肺动静脉畸形:一项 18 年回顾性研究。
Lung. 2020 Aug;198(4):679-686. doi: 10.1007/s00408-020-00367-w. Epub 2020 Jul 9.
9
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).遗传性出血性毛细血管扩张症(伦杜-奥斯勒病)的肺血管表现
Respiration. 2007;74(4):361-78. doi: 10.1159/000103205.
10
Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients.肺动静脉畸形与遗传性出血性毛细血管扩张症患者的无症状脑梗死相关。
Cerebrovasc Dis. 2017;44(3-4):179-185. doi: 10.1159/000478734. Epub 2017 Jul 27.

引用本文的文献

1
Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症的心脏和血流动力学表现
Int J Angiol. 2022 Jul 9;31(2):75-82. doi: 10.1055/s-0042-1745842. eCollection 2022 Jun.
2
Pulmonary arteriovenous malformations presenting with upper back pain in an adult: A case report and literature review.成人肺动静脉畸形伴上背部疼痛:一例报告及文献复习
Radiol Case Rep. 2021 Jun 8;16(8):1988-1992. doi: 10.1016/j.radcr.2021.05.009. eCollection 2021 Aug.
3
Approach to Pulmonary Arteriovenous Malformations: A Comprehensive Update.

本文引用的文献

1
Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association.超声心动图对比检查中肺右向左分流程度与脑部并发症:显著关联。
Chest. 2013 Aug;144(2):542-548. doi: 10.1378/chest.12-1599.
2
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH.遗传性出血性毛细血管扩张症和严重肺动脉高压导致的肺动静脉畸形破裂致死。
Eur Respir Rev. 2009 Mar;18(111):42-6. doi: 10.1183/09059180.00011113.
3
Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study.
肺动静脉畸形的治疗方法:全面更新
J Clin Med. 2020 Jun 19;9(6):1927. doi: 10.3390/jcm9061927.
4
Pulmonary arteriovenous malformations: diagnostic and treatment characteristics.肺动静脉畸形:诊断和治疗特征。
J Bras Pneumol. 2019 Jun 19;45(4):e20180137. doi: 10.1590/1806-3713/e20180137.
5
Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.肺动脉高压与遗传性出血性毛细血管扩张症。
Int J Mol Sci. 2018 Oct 17;19(10):3203. doi: 10.3390/ijms19103203.
6
Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia.经胸对比超声心动图对遗传性出血性毛细血管扩张症患者右向左分流定量分析的可重复性
Neth Heart J. 2018 Apr;26(4):203-209. doi: 10.1007/s12471-018-1094-4.
7
Long-term outcomes of patients with pulmonary arteriovenous malformations considered for lung transplantation, compared with similarly hypoxaemic cohorts.与类似低氧血症队列相比,考虑进行肺移植的肺动静脉畸形患者的长期预后。
BMJ Open Respir Res. 2017 Oct 13;4(1):e000198. doi: 10.1136/bmjresp-2017-000198. eCollection 2017.
8
Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia.据报告,肺动静脉畸形栓塞术可改善遗传性出血性毛细血管扩张症患者亚组的鼻出血症状。
ERJ Open Res. 2016 Apr 29;2(2). doi: 10.1183/23120541.00035-2016. eCollection 2016 Apr.
9
Pulmonary hypertension in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中的肺动脉高压
World J Cardiol. 2015 May 26;7(5):230-7. doi: 10.4330/wjc.v7.i5.230.
10
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中表型的循环因素
Front Genet. 2015 Apr 9;6:101. doi: 10.3389/fgene.2015.00101. eCollection 2015.
遗传性出血性毛细血管扩张症患者根据基因型的肺右向左分流的真实患病率:经胸超声心动图造影研究。
Chest. 2010 Oct;138(4):833-9. doi: 10.1378/chest.09-1849. Epub 2010 Feb 12.
4
Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure.卵圆孔未闭和房间隔缺损封堵的血流动力学效应:经皮分流封堵术期间的比较
Clin Physiol Funct Imaging. 2010 Jan;30(1):64-8. doi: 10.1111/j.1475-097X.2009.00905.x. Epub 2009 Oct 4.
5
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗工作组,得到国际心肺移植学会(ISHLT)认可。
Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27.
6
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.国际遗传性出血性毛细血管扩张症诊断和管理指南。
J Med Genet. 2011 Feb;48(2):73-87. doi: 10.1136/jmg.2009.069013. Epub 2009 Jun 23.
7
Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study.经胸对比超声心动图筛查肺动静脉畸形:一项前瞻性研究。
Eur Respir J. 2009 Jan;33(1):85-91. doi: 10.1183/09031936.00049008. Epub 2008 Sep 17.
8
Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure.肺动静脉畸形的栓塞治疗:对肺动脉压无一致影响。
Eur Respir J. 2008 Jul;32(1):162-9. doi: 10.1183/09031936.00126207. Epub 2008 Apr 2.
9
The effect of temperature on systolic blood pressure.温度对收缩压的影响。
Blood Press Monit. 2007 Jun;12(3):195-203. doi: 10.1097/MBP.0b013e3280b083f4.
10
Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients.肺动静脉畸形的栓塞治疗:112例患者的长期结果
J Vasc Interv Radiol. 2004 May;15(5):451-6. doi: 10.1097/01.rvi.0000126811.05229.b6.